Prestige Consumer Healthcare Inc. (PBH) — Financial statements
Income statement, balance sheet, and cash flow for Prestige Consumer Healthcare Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,089↓4.3% | 1,138↑1.1% | 1,125↓0.2% | 1,128↑3.8% | 1,087 | |
| Cost of Revenue | 514↑2.1% | 503↑0.5% | 501↓0.3% | 502↑7.8% | 466 | |
| Gross Profit | 575↓9.4% | 634↑1.6% | 624↓0.1% | 625↑0.7% | 621 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 116↑7.6% | 108↑1.9% | 106↓1.1% | 107↓0.1% | 107 | |
| Selling & Marketing Expenses | 149↓4.5% | 156↑1.6% | 153↑5.7% | 145↓7.8% | 157 | |
| SG&A Expenses | 265↑0.5% | 264↑1.7% | 259↑2.8% | 252↓4.7% | 265 | |
| Other Expenses | 0.00↓100.0% | 34↑49.7% | 23↓94.3% | 395↑1424.8% | 26 | |
| Operating Expenses | 265↓10.9% | 298↑5.6% | 282↓56.5% | 648↑122.8% | 291 | |
| Total Costs & Expenses | 779↓2.7% | 801↑2.3% | 783↓31.9% | 1,150↑52.0% | 757 | |
| Operating Results | ||||||
| Operating Income | 309↓8.1% | 337↓1.7% | 342↑1627.7% | -22↓106.8% | 330 | |
| Depreciation & Amortization | 31↑3.6% | 30↓1.6% | 31↓6.0% | 33↑1.7% | 32 | |
| EBITDA | 341↓5.9% | 362↓3.2% | 374↑4648.0% | 8↓97.8% | 359 | |
| EBIT | 309↓6.8% | 332↓3.3% | 343↑1486.6% | -25↓107.6% | 327 | |
| Interest & Other Income | ||||||
| Net Interest Income | -42↑11.1% | -48↑29.1% | -67↑2.9% | -69↓7.6% | -64 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 42↓11.1% | 48↓29.1% | 67↓2.9% | 69↑7.6% | 64 | |
| Non-Operating Income | 0.00↓100.0% | 5↑755.3% | -0.76↓132.4% | 2↓26.4% | 3 | |
| Other Income / Expenses | -52↑1.3% | -53↑20.8% | -66↑7.1% | -72↓6.0% | -67 | |
| Income Before Tax | 257↓9.4% | 284↑3.0% | 276↑393.9% | -94↓135.8% | 262 | |
| Income Tax Expense | 67↓3.4% | 70↑4.3% | 67↑674.4% | -12↓120.3% | 57 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 190↓11.3% | 215↑2.5% | 209↑354.3% | -82↓140.1% | 205 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 190↓11.3% | 215↑2.5% | 209↑354.3% | -82↓140.1% | 205 | |
| Bottom-Line Net Income | 190↓11.3% | 215↑2.5% | 209↑354.3% | -82↓140.1% | 205 | |
| EPS (Basic) | 3.93↓9.0% | 4.32↑2.6% | 4.21↑355.2% | -1.65↓140.3% | 4.09 | |
| EPS (Diluted) | 3.91↓8.9% | 4.29↑2.9% | 4.17↑352.7% | -1.65↓140.8% | 4.04 | |
| Weighted Average Shares | 48↓2.5% | 50↓0.1% | 50↓0.3% | 50↓0.7% | 50 | |
| Weighted Average Diluted Shares | 49↓2.7% | 50↓0.2% | 50↑0.6% | 50↓1.9% | 51 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.